本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mereo Biopharma Group Plc

2.33
+0.03001.30%
盘后2.390.0600+2.58%17:37 EDT
成交量:356.68万
成交额:841.74万
市值:3.70亿
市盈率:-7.97
高:2.42
开:2.30
低:2.26
收:2.30
数据加载中...
2024/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/21

SEC问询函

Form CORRESP - Correspondence
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/15

重要事件披露

Form 8-K - Current report
2024/04/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/15

重要事件披露

Form 8-K - Current report
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]